Every round on record, with the sources behind each and the investors on them.
A provider of an AI platform for clinical trial design and setup
cori-clinical.comLinkedInLondon, UKMedtechFounded 2025
10 sources · checked 1 time, last 1h ago
Source 3 reports €3.8 million; the company's release reports $4 million, which is preferred under the source-priority rule.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Seed | $4M ~$4M financing total | 2026-10-07 | BREEGA | 10 outlets. #13 in Trending |
10 sources · checked 1 time, last 1h ago [ VERIFIED · CORRECTED ] read against 4 of 10 sources
Source 3 reports €3.8 million; the company's release reports $4 million, which is preferred under the source-priority rule. | ||||
Cori Clinical builds an AI-guided workspace that turns a clinical-trial brief into a protocol, submission package and operational plans for sponsors and CROs.
Clinical-trial start-up is fragmented, and Cori's funding announcement says substantial protocol amendments carry direct costs of around $141,000 for a Phase II protocol and $535,000 for Phase III while also extending recruitment and study duration. The $4 million seed is intended to expand delivery, product and regulatory intelligence as Cori builds on early traction with two of the top five enterprise CROs and Erasmus MC, while the company estimates its approach could cut average trial set-up costs by at least 33%.
Checked against 10 sources yesterday